0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted September 13, 2022Australian Physiotherapy and Occupational Therapy insights on implementing beach-based therapeutic interventions for people with disability READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 31, 2022Exploring the effects of a brief online self-implemented mindfulness-based task: A pilot study READ MORE
0 By Tennille Luker In NSW, QLD, TAS, VIC, WAPosted August 30, 2022A study to investigate the feasibility of smartphone-based self-monitoring to characterise cognitive and neurological impairment in participants with multiple sclerosis READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 18, 2022Social connectedness and long-term health conditions READ MORE
0 By Tennille Luker In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WAPosted August 9, 2022Recommendations for a core outcome set for evaluating falls prevention interventions among adults with Multiple Sclerosis, Parkinson’s Disease and stroke: A Consensus-Based Approach READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted August 3, 2022Investigating social cognitive factors associated with chronic non-cancer pain and pain management READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted June 23, 2022Crisis Resilience in MS; considering experience of persons with MS to improve crisis and disaster management READ MORE
0 By Tennille Luker In QLD, VICPosted June 21, 2022An early feasibility study of the safety of an endovascular Motor Neuroprosthesis (MNP) in participants with severe upper limb dysfunction READ MORE
0 By Tennille Luker In ACT, NSW, NT, QLD, SA, TAS, VIC, WAPosted June 16, 2022The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis READ MORE
0 By Tennille Luker In NSW, QLD, VICPosted June 7, 2022A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid) READ MORE
